Renol Polychem Stock Price Today (NSE: RNPL)
Fundamental Score
Renol Polychem Share Price Live NSE/BSE & Institutional Fundamental Analysis
Renol Polychem share price today is ₹146.00, up +0.00% on NSE/BSE as of 30 September 2025. Renol Polychem (RNPL) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of ₹115.98 (Cr). The 52-week high for RNPL share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 22.39x, RNPL is currently trading below its industry average P/E of 29.20x. The company has a Return on Equity (ROE) of 45.41% and a debt-to-equity ratio of 0.01.
Renol Polychem Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Renol Polychem Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Renol Polychem Share Price
The specialty chemicals sector is experiencing a period of dynamic growth, driven by increased demand for tailored solutions in various industries. This creates both opportunities and challenges for companies operating within it. A close examination of Renol Polychem share price is crucial to understanding its position within this evolving landscape. Currently trading at ₹146.0, with a PE ratio of 22.39, Renol Polychem's valuation needs careful consideration in light of its peers and performance metrics.
One key area of strength for Renol Polychem is its impressive Return on Capital Employed (ROCE) of 46.09%. This indicates a high level of efficiency in generating profits from its capital investments. A consistently high ROCE, such as this, can contribute significantly to a company's economic moat, making it more difficult for competitors to erode its profitability and market share. It suggests strong management practices and a potential competitive advantage in sourcing materials or production processes.
When comparing Renol Polychem to its sector peers like
Amal, it's important to look beyond simple financial ratios. For example, while Amal might exhibit similar top-line growth, a deeper dive into management quality reveals subtle differences in strategic decision-making and risk management. Analyst interviews suggest Renol Polychem's management has a strong focus on sustainable growth, prioritizing long-term value creation over short-term gains. This is an observational note, and requires further research to quantify its impact.However, the PE ratio of 22.39 also warrants further investigation. While not excessively high, it's important to compare it not just to the sector average, but also to historical trends for Renol Polychem itself. Is the company's growth trajectory sustainable enough to justify this valuation? A thorough assessment would involve examining the company's order book, future expansion plans, and potential threats from new market entrants.
This financial analysis of Renol Polychem is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra. It aims to provide an objective view of the company's financial health based on publicly available data. This is purely an observational analysis and does not constitute investment advice. Investors should conduct their own due diligence before making any investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Renol Polychem Fundamental Analysis & Valuation Benchmarking
Educational evaluation of RNPL across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Return on Equity (45.41%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (46.09%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 22.39 vs Industry: 29.20)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (38.81%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.01)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (12.93x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (69.10%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Limited Institutional Interest (FII+DII: 4.31%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Renol Polychem Financial Statements
Comprehensive financial data for Renol Polychem including income statement, balance sheet and cash flow
About RNPL (Renol Polychem)
Renol Polychem (RNPL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Specialty Chemicals sector with a current market capitalisation of ₹115.98 (Cr). Renol Polychem has delivered a Return on Equity (ROE) of 45.41% and a ROCE of 46.09%. The debt-to-equity ratio stands at 0.01, reflecting the company's capital structure. Investors tracking RNPL share price can monitor key metrics including P/E ratio, promoter holding of 69.10%, and quarterly earnings growth.
Company Details
RNPL Share Price: Frequently Asked Questions
What is the current share price of Renol Polychem (RNPL)?
As of 30 Sept 2025, 03:25 pm IST, Renol Polychem share price is ₹146.00. The RNPL stock has a market capitalisation of ₹115.98 (Cr) on NSE/BSE.
Is RNPL share price Overvalued or Undervalued?
RNPL share price is currently trading at a P/E ratio of 22.39x, compared to the industry average of 29.20x. Based on this relative valuation, the Renol Polychem stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of RNPL share price?
The 52-week high of RNPL share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Renol Polychem share price?
Key factors influencing RNPL share price include quarterly earnings growth (Sales Growth: 38.81%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Renol Polychem a good stock for long-term investment?
Renol Polychem shows a 5-year Profit Growth of N/A% and an ROE of 45.41%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.01 before investing in RNPL shares.
How does Renol Polychem compare with its industry peers?
Renol Polychem competes with major peers in the Specialty Chemicals. Investors should compare RNPL share price P/E of 22.39x and ROE of 45.41% against the industry averages to determine competitive standing.
What is the P/E ratio of RNPL and what does it mean?
RNPL share price has a P/E ratio of 22.39x compared to the industry average of 29.20x. Investors pay ₹22 for every ₹1 of annual earnings.
How is RNPL performing according to Bull Run's analysis?
RNPL has a Bull Run fundamental score of 20.5/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does RNPL belong to?
RNPL operates in the Specialty Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Renol Polychem share price.
What is Return on Equity (ROE) and why is it important for RNPL?
RNPL has an ROE of 45.41%, which indicates excellent management efficiency. ROE measures how efficiently Renol Polychem generates profits from shareholders capital.
How is RNPL debt-to-equity ratio and what does it indicate?
RNPL has a debt-to-equity ratio of 0.01, which indicates conservative financing with low financial risk.
What is RNPL dividend yield and is it a good dividend stock?
RNPL offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Renol Polychem shares.
How has RNPL share price grown over the past 5 years?
RNPL has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in RNPL and why does it matter?
Promoters hold 69.10% of RNPL shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Renol Polychem.
What is RNPL market capitalisation category?
RNPL has a market capitalisation of ₹116 crores, placing it in the Small-cap category.
How volatile is RNPL stock?
RNPL has a beta of N/A. A beta > 1 suggests the Renol Polychem stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is RNPL operating profit margin trend?
RNPL has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is RNPL quarterly performance?
Recent quarterly performance shows Renol Polychem YoY Sales Growth of 38.81% and YoY Profit Growth of 8.18%.
What is the institutional holding pattern in RNPL?
RNPL has FII holding of 0.68% and DII holding of 3.63%. Significant institutional holding often suggests professional confidence in the Renol Polychem stock.